Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Coherus, In Ring As A Biosimilar Contender, Hopes To Smack Down Humira

Oct 19 2016

• By Brenda Sandburg

3D illustration of molecular structure and communication concept on dark background. science, connection, biology, medicine

Related Content

Sandoz Skips Enbrel Biosimilar Patent Dance, Spurs Infringement Suit

Mar 01 2016

Amgen's Amjevita Approved As First Biosimilar To AbbVie's Humira

Sep 24 2016

Biosimilar Litigation: Battles Continue Over Launch Notification, Access To FDA Info

Jul 26 2016

Biosimilars Still Flummoxed By Neulasta: Sponsors Now 0 For 2 At FDA

Jul 19 2016

AbbVie v. Amgen Round One: Humira Biosimilar Infringes 10 Patents, Suit Claims

Aug 05 2016

FDA Biosimilar Policy Continues To Evolve With Approval Of Sandoz Erelzi

Aug 31 2016

Related Companies

Coherus Oncology, Inc.

Novartis AG

Amgen, Inc.

Pfizer Inc.

AbbVie Inc.

Apotex Inc.

Eli Lilly and Company

Daiichi Sankyo Co., Ltd.

Baxalta Incorporated

Baxter International Inc.

Takeda Pharmaceutical Co. Ltd.

Roche Holding AG

InteKrin Therapeutics, Inc.

Additional Topics

Biosimilars Companies Intellectual Property Clinical Trials Commercial Legal Issues BioPharmaceutical

More from Biosimilars

More from Products

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window